Egfr blood test

The estimated glomerular filtration rate (eGFR) is a key laboratory test used to assess kidney function. It provides an estimate of how well the kidneys are filtering waste from the blood. Measuring eGFR is essential for early detection and monitoring of chronic kidney disease and other renal conditions.

Physiology of Glomerular Filtration

The kidneys filter blood through structures called glomeruli, removing waste products while retaining essential substances. Understanding glomerular filtration is crucial for interpreting eGFR results.

• Structure and function of the glomerulus: The glomerulus is a network of capillaries surrounded by Bowman’s capsule. It serves as the primary site for blood filtration.
• Filtration process and determinants of GFR: Glomerular filtration rate is influenced by hydrostatic and oncotic pressures, the permeability of the glomerular membrane, and blood flow through the kidneys.
• Factors affecting kidney filtration: Age, blood pressure, hydration status, and underlying diseases such as diabetes and hypertension can modify the filtration efficiency of the glomeruli.

eGFR Test Overview

The eGFR test estimates the rate at which the kidneys filter blood, providing a non-invasive assessment of renal function. It is widely used in routine clinical practice to identify kidney impairment.

• Definition of eGFR: Estimated glomerular filtration rate is calculated using serum biomarkers, typically creatinine, along with demographic factors.
• Purpose of the test: To detect early kidney dysfunction, monitor progression of kidney disease, and guide medical management including medication dosing.
• Clinical indications for measuring eGFR: Screening for chronic kidney disease, evaluation of kidney function in patients with diabetes or hypertension, and assessment prior to nephrotoxic drug therapy.

Methods of Estimating GFR

Several methods are used to estimate glomerular filtration rate, each with advantages and limitations. These methods help clinicians assess kidney function accurately in different clinical scenarios.

Serum Creatinine-Based Equations

• MDRD (Modification of Diet in Renal Disease) equation: Uses serum creatinine, age, sex, and race to estimate GFR. It is widely used for patients with chronic kidney disease.
• CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation: Provides a more accurate estimation of GFR, especially for patients with near-normal kidney function.
• Limitations of creatinine-based calculations: Muscle mass, diet, and certain medications can affect creatinine levels and lead to inaccurate eGFR values.

Cystatin C-Based Equations

• Advantages over creatinine: Less affected by muscle mass, age, or diet, providing a more reliable estimate in some populations.
• Combined creatinine and cystatin C formulas: Using both markers improves the accuracy of eGFR estimation, particularly in patients with intermediate kidney function.

Direct GFR Measurement

• Inulin clearance: Considered the gold standard for measuring GFR but is rarely used in clinical practice due to complexity.
• Radioisotope clearance tests: Use radiolabeled tracers to measure kidney filtration. These tests are accurate but expensive and mainly used in research or complex clinical cases.

Procedure and Sample Collection

Proper procedure and sample handling are essential for accurate eGFR measurement. The test is simple, minimally invasive, and performed routinely in clinical laboratories.

• Patient preparation: Usually no fasting is required. Patients should avoid excessive exercise or high-protein meals immediately before the test.
• Blood sample collection: A venous blood sample is drawn, typically from the arm, using standard phlebotomy techniques.
• Laboratory handling and analysis: Serum creatinine is measured, and eGFR is calculated using standard equations. Some laboratories also measure cystatin C when indicated.

Interpretation of eGFR Results

Interpreting eGFR values helps clinicians assess kidney function, identify chronic kidney disease, and guide management decisions.

• Normal eGFR ranges by age and sex: In adults, a normal eGFR is typically ≥90 mL/min/1.73 m². Values naturally decline with age.
• Stages of chronic kidney disease (CKD) based on eGFR:
  

  CKD Stage	eGFR (mL/min/1.73 m²)	Description
  Stage 1	≥90	Normal or high function with kidney damage
  Stage 2	60–89	Mild decrease in function
  Stage 3a	45–59	Mild to moderate decrease
  Stage 3b	30–44	Moderate to severe decrease
  Stage 4	15–29	Severe decrease
  Stage 5	<15	Kidney failure

• Factors affecting accuracy: Hydration status, medications, muscle mass, and acute illnesses can alter eGFR values.

Clinical Significance

The eGFR test is crucial in diagnosing, monitoring, and managing kidney-related conditions. It also informs other aspects of patient care.

• Detection and monitoring of CKD: Early identification allows timely interventions to slow disease progression.
• Medication dosing adjustments in renal impairment: Many drugs require dose modifications based on eGFR to prevent toxicity.
• Risk assessment for cardiovascular disease and complications: Reduced eGFR is associated with increased risk of cardiovascular events and mortality.

Limitations and Considerations

While eGFR is a valuable tool for assessing kidney function, certain limitations and considerations must be recognized to avoid misinterpretation.

• Influence of age, sex, and ethnicity: Standard eGFR equations include demographic adjustments, but individual variability can affect accuracy.
• Impact of acute kidney injury versus chronic conditions: eGFR reflects steady-state kidney function and may not accurately detect rapid changes in acute kidney injury.
• Potential sources of laboratory error: Variations in creatinine measurement methods, sample handling, and timing can lead to inaccurate results.

Alternative and Complementary Tests

Other tests can complement eGFR for a more comprehensive evaluation of kidney function and risk assessment.

• Urine albumin-to-creatinine ratio (UACR): Detects early kidney damage by measuring protein excretion in urine.
• Serum creatinine and BUN: Provides basic assessment of kidney function and can help corroborate eGFR findings.
• Imaging studies for kidney structure: Ultrasound, CT, or MRI may be used to detect anatomical abnormalities contributing to renal dysfunction.

References

1. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165–180.
2. Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Am J Kidney Dis. 2014;63(5):713–735.
3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1–150.
4. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–S266.
5. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
6. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–2047.
7. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009;20(11):2305–2313.
8. Fox CH, Inker LA, Levey AS. Estimating glomerular filtration rate. Clin J Am Soc Nephrol. 2012;7:8–15.